Ratings by Cantor Fitzgerald (Brandon Folkes)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/11/2025 | Cerus | CERS | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/2/2025 | Cerus | CERS | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/21/2025 | MannKind | MNKD | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/18/2025 | Cerus | CERS | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/10/2025 | Cerus | CERS | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/26/2025 | Jazz Pharmaceuticals | JAZZ | Downgrade | Neutral (Overweight) |
139.67 (230.93) |
65.34% | Details | |
| 5/3/2024 | Cerus | CERS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2023 | Omeros Corp. | OMER | Downgrade | Neutral (Overweight) |
1.26 (10.16) |
706.35% | Details | |
| 11/8/2023 | Cerus | CERS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/14/2023 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2023 | MannKind | MNKD | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2023 | ANI Pharmaceuticals | ANIP | Maintain | Neutral (N/A) |
|
Details | ||
| 3/13/2023 | Eagle Pharmaceuticals | EGRX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2023 | Cerus | CERS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/17/2023 | AstraZeneca | AZN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/9/2023 | Veru, Inc. | VERU | Maintain | Overweight (N/A) |
|
Details | ||
| 1/10/2023 | Amryt | AMYT | Downgrade | Neutral (Overweight) |
7.00 (14.70) |
110% | Details | |
| 1/5/2023 | Collegium Pharmaceutical | COLL | Maintain | Overweight (N/A) |
|
Details | ||
| 12/5/2022 | Veru, Inc. | VERU | Maintain | Overweight (N/A) |
|
Details | ||
| 11/22/2022 | Opiant Pharma | OPNT | Downgrade | Neutral (Overweight) |
20.07 (20.65) |
2.89% | Details | |
| 11/22/2022 | Opiant Pharma | OPNT | Downgrade | Neutral (Overweight) |
20.07 (20.07) |
0% | Details | |
| 11/22/2022 | Redhill Biopharma | RDHL | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2022 | Omeros Corp. | OMER | Maintain | Overweight (N/A) |
|
Details | ||
| 11/9/2022 | Heron Therapeutics | HRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/9/2022 | Emergent BioSolutions | EBS | Maintain | Neutral (N/A) |
|
Details | ||
| 11/8/2022 | MannKind | MNKD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2022 | Eagle Pharmaceuticals | EGRX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/2/2022 | Sorrento Therapeutics | SRNE | New Coverage | Overweight (N/A) |
1.58 (0.00) |
-100% | Details | |
| 7/28/2022 | ObsEva | OBSV | Downgrade | Neutral (Overweight) |
0.40 (0.10) |
-75% | Details | |
| 6/3/2022 | ObsEva | OBSV | New Coverage | Overweight (N/A) |
1.96 (0.10) |
-94.9% | Details | |
| 5/23/2022 | MannKind | MNKD | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/29/2022 | Emergent BioSolutions | EBS | Downgrade | Neutral (Buy) |
36.61 (7.93) |
-78.34% | Details | |
| 4/22/2022 | SeaSpine Holdings | SPNE | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/31/2022 | Trevena | TRVN | Maintain | Overweight (N/A) |
|
Details | ||
| 3/15/2022 | ANI Pharmaceuticals | ANIP | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2022 | Amryt | AMYT | Maintain | Overweight (N/A) |
|
Details | ||
| 3/1/2022 | Heron Therapeutics | HRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 2/25/2022 | Journey Medical Corp. | DERM | New Coverage | Overweight (N/A) |
5.07 (6.06) |
19.53% | Details | |
| 2/18/2022 | BioDelivery Sciences International | BDSI | Downgrade | Neutral (Overweight) |
5.55 (5.59) |
0.72% | Details | |
| 2/15/2022 | Collegium Pharmaceutical | COLL | Upgrade | Buy (Neutral) |
17.59 (31.06) |
76.58% | Details | |
| 1/27/2022 | Alkermes | ALKS | Upgrade | Overweight (Neutral) |
25.01 (42.76) |
70.97% | Details | |
| 1/20/2022 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details | ||
| 1/18/2022 | Omeros Corp. | OMER | Maintain | Overweight (N/A) |
|
Details | ||
| 12/13/2021 | Veru, Inc. | VERU | Maintain | Overweight (N/A) |
|
Details | ||
| 12/3/2021 | Rani Therapeutics Holdsing s | RANI | Maintain | Overweight (N/A) |
|
Details | ||
| 12/1/2021 | AcelRx Pharmaceuticals | ACRX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/11/2021 | MannKind | MNKD | Maintain | Overweight (N/A) |
|
Details | ||
| 11/9/2021 | Eagle Pharmaceuticals | EGRX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/5/2021 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/27/2021 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/18/2021 | Omeros Corp. | OMER | Maintain | Overweight (N/A) |
|
Details | ||
| 9/22/2021 | IMV Inc. | IMV | New Coverage | Overweight (N/A) |
1.69 (0.82) |
-51.48% | Details | |
| 8/31/2021 | Redhill Biopharma | RDHL | New Coverage | Overweight (N/A) |
8.59 (1.00) |
-88.36% | Details | |
| 8/24/2021 | Rani Therapeutics Holdsing s | RANI | New Coverage | Overweight (N/A) |
17.13 (0.88) |
-94.86% | Details | |
| 8/9/2021 | ViewRay Inc. | VRAY | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2021 | Collegium Pharmaceutical | COLL | Downgrade | Neutral (Overweight) |
24.94 (31.06) |
24.54% | Details | |
| 7/28/2021 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 6/30/2021 | Sanara MedTech | SMTI | New Coverage | Overweight (N/A) |
36.66 (20.97) |
-42.8% | Details | |
| 6/16/2021 | Kindred Biosciences | KIN | Downgrade | Neutral (Buy) |
6.34 (9.25) |
45.9% | Details | |
| 5/26/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 5/13/2021 | Heron Therapeutics | HRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2021 | Chiasma | CHMA | Maintain | Overweight (N/A) |
|
Details | ||
| 4/28/2021 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 4/20/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 4/6/2021 | SeaSpine Holdings | SPNE | Maintain | Overweight (N/A) |
|
Details | ||
| 4/5/2021 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2021 | MannKind | MNKD | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2021 | AxoGen, Inc. | AXGN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/19/2021 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/10/2021 | Veru, Inc. | VERU | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2021 | AxoGen, Inc. | AXGN | Maintain | Overweight (N/A) |
|
Details | ||
| 1/4/2021 | ViewRay Inc. | VRAY | Maintain | Overweight (N/A) |
|
Details | ||
| 12/14/2020 | Veru, Inc. | VERU | Maintain | Overweight (N/A) |
|
Details | ||
| 11/2/2020 | Aziyo Biologics Inc. | AZYO | New Coverage | Overweight (N/A) |
10.82 (1.49) |
-86.23% | Details | |
| 10/5/2020 | ViewRay Inc. | VRAY | Maintain | Overweight (N/A) |
|
Details | ||
| 8/28/2020 | Trevena | TRVN | New Coverage | Overweight (N/A) |
1.53 (2.50) |
63.4% | Details | |
| 8/14/2020 | Pfenex Inc. | PFNX | Downgrade | Neutral (Overweight) |
12.80 (12.75) |
-0.39% | Details | |
| 8/6/2020 | ANI Pharmaceuticals | ANIP | Maintain | Neutral (N/A) |
|
Details | ||
| 7/29/2020 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/28/2020 | Kindred Biosciences | KIN | Maintain | Overweight (N/A) |
|
Details | ||
| 7/21/2020 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details | ||
| 7/16/2020 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details | ||
| 7/9/2020 | Amryt | AMYT | New Coverage | Overweight (N/A) |
24.70 (14.70) |
-40.49% | Details | |
| 6/30/2020 | Optinose | OPTN | Maintain | Overweight (N/A) |
|
Details | ||
| 6/29/2020 | Heron Therapeutics | HRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 6/16/2020 | ViewRay Inc. | VRAY | New Coverage | Overweight (N/A) |
2.22 (0.03) |
-98.65% | Details | |
| 6/16/2020 | SeaSpine Holdings | SPNE | New Coverage | Overweight (N/A) |
11.08 (9.54) |
-13.9% | Details | |
| 6/16/2020 | SI-BONE Inc. | SIBN | New Coverage | Overweight (N/A) |
16.76 (13.92) |
-16.95% | Details | |
| 6/16/2020 | RTI Biologics | RTIX | New Coverage | Overweight (N/A) |
2.98 (3.14) |
5.37% | Details | |
| 6/16/2020 | Cerus | CERS | New Coverage | Overweight (N/A) |
6.04 (2.66) |
-55.96% | Details | |
| 6/16/2020 | AxoGen, Inc. | AXGN | New Coverage | Overweight (N/A) |
9.20 (40.63) |
341.63% | Details | |
| 5/7/2020 | ANI Pharmaceuticals | ANIP | Downgrade | Neutral (Overweight) |
36.96 (75.23) |
103.54% | Details | |
| 4/28/2020 | Optinose | OPTN | Maintain | Overweight (N/A) |
|
Details | ||
| 4/20/2020 | Eagle Pharmaceuticals | EGRX | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/5/2020 | Optinose | OPTN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2020 | Momenta Pharmaceuticals | MNTA | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2020 | Heron Therapeutics | HRTX | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/7/2020 | Collegium Pharmaceutical | COLL | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2019 | ANI Pharmaceuticals | ANIP | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2019 | MannKind | MNKD | Maintain | Overweight (N/A) |
|
Details | ||
| 10/25/2019 | Pfenex Inc. | PFNX | New Coverage | Overweight (N/A) |
9.42 (12.80) |
35.88% | Details | |
| 10/25/2019 | MannKind | MNKD | New Coverage | Overweight (N/A) |
1.30 (3.36) |
158.46% | Details | |
| 10/23/2019 | Alkermes | ALKS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/1/2019 | Heron Therapeutics | HRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/13/2019 | Chiasma | CHMA | Maintain | Overweight (N/A) |
|
Details | ||
| 7/2/2019 | Veru, Inc. | VERU | New Coverage | Overweight (N/A) |
2.13 (2.25) |
5.63% | Details | |
| 6/28/2019 | Chiasma | CHMA | Maintain | Overweight (N/A) |
|
Details | ||
| 6/25/2019 | Rockwell Medical Technologies | RMTI | New Coverage | Overweight (N/A) |
2.99 (0.68) |
-77.26% | Details | |
| 5/6/2019 | Omeros Corp. | OMER | New Coverage | Overweight (N/A) |
19.18 (10.16) |
-47.03% | Details | |
| 5/1/2019 | Heron Therapeutics | HRTX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/13/2019 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/7/2019 | Chiasma | CHMA | New Coverage | Overweight (N/A) |
5.25 (3.79) |
-27.81% | Details | |
| 3/1/2019 | BioDelivery Sciences International | BDSI | Maintain | Overweight (N/A) |
|
Details | ||
| 2/22/2019 | BioDelivery Sciences International | BDSI | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/12/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 1/22/2019 | INSYS Therapeutics | INSy | New Coverage | Overweight (N/A) |
4.40 (0.29) |
-93.41% | Details | |
| 1/2/2019 | Heron Therapeutics | HRTX | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/9/2018 | BioDelivery Sciences International | BDSI | Maintain | Overweight (N/A) |
|
Details | ||
| 11/7/2018 | Momenta Pharmaceuticals | MNTA | Maintain | Neutral (N/A) |
|
Details | ||
| 11/5/2018 | AcelRx Pharmaceuticals | ACRX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/2/2018 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/1/2018 | Eagle Pharmaceuticals | EGRX | Downgrade | Neutral (Overweight) |
49.24 (2.14) |
-95.65% | Details | |
| 10/10/2018 | AcelRx Pharmaceuticals | ACRX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/28/2018 | Opiant Pharma | OPNT | Maintain | Overweight (N/A) |
|
Details | ||
| 9/11/2018 | Emergent BioSolutions | EBS | Maintain | Overweight (N/A) |
|
Details |
